07:00 , May 24, 2010 |  BC Week In Review  |  Company News

Arch Biopartners, Arch Biotech Inc. deal

Investment company Arch Biopartners (formerly Foccini International Inc.) exercised its option to acquire Arch Biotech and two IP-holding entities in a stock deal valued at C$9 million ($8.7 million). Arch Biopartners issued 14.2 million shares...